Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Seeking Alpha
William Peters - CFO, Executive VP of Finance, Treasurer & Director Dan Dischner - Senior Vice President of Human Resources & Corporate Communication Conference Call Participants Glen Santangelo - Barclays Bank PLC, Research Division Presentation Glen Santangelo Barclays Bank PLC, Research Division All right. Well, thank you. Good afternoon, everybody. Thank you for joining us. We're very excited to be hosting Amphastar Pharmaceuticals. To my right is Bill Peters, the CFO; and to his right is Dan Dischner, who's in charge of the Corporate Communications and some other things at Amphastar. For those of you who don't know me, I'll introduce myself. I'm Glen Santangelo. I'm the analyst at Barclays that covers the spec pharma and animal health space, among some other things. And we're excited to have you both here today. So thank you for joining us. William Peters CFO, Executive VP of Finance, Treasurer & Director Thank you for having us. Dan Dischner Senior Vic
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals (AMPH) had its "equal weight" rating reaffirmed by Wells Fargo & Company. They now have a $19.00 price target on the stock, down from $30.00.MarketBeat
- Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals (AMPH) had its "neutral" rating reaffirmed by Piper Sandler. They now have a $21.00 price target on the stock, down from $25.00.MarketBeat
- Earnings Miss: Amphastar Pharmaceuticals, Inc. Missed EPS By 75% And Analysts Are Revising Their Forecasts [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 5/7/26 - Miss
AMPH
Sec Filings
- 5/7/26 - Form 10-Q
- 5/7/26 - Form 8-K
- 4/13/26 - Form ARS
- AMPH's page on the SEC website